Award
Purchase Order #75N98026P00521
Proteomic Analysis Service Contract Awarded to Psomagen Inc for Sickle Cell Study
Buyer
National Institutes of Health
Award Amount
$199,994.72
Ceiling
$199,994.72
Awarded
May 14, 2026
Period of Performance
May 14, 2026 – Nov 21, 2026
Identifier
75N98026P00521
NAICS
541380
This award represents a purchase order contract awarded to Psomagen Inc, a company specializing in advanced genomic and proteomic services. The contract procures high-throughput proteomic analysis services using the Olink Explore HT platform to support a sickle cell disease study under the National Heart, Lung, and Blood Institute (NHLBI). This specialized service is critical for advancing biomedical research on sickle cell disease, facilitating the identification of protein biomarkers essential for understanding disease mechanisms. The work involves detailed analysis of biological samples to generate comprehensive proteomic data. Awarded through a competitive process, this agreement reflects the importance of precision proteomic tools in health research. The contract covers performance during a defined multi-month period, ensuring timely delivery of the analytical results. The work is performed at Rockville, Maryland, supporting NASA-related or NIH-centered research efforts. While no subcontractors or prior contracts are reported, the focused timeline and service specification highlight the importance of this procurement for ongoing disease research initiatives.
Description
NHLBI: SERVICE: OLINK EXPLORE HT PROTEOMIC ANALYSIS FOR SICKLE CELL DISEASE STUDY: SEVERABLE